Monocyte chemoattractant protein-1: A dichotomous role in cardiac remodeling following acute myocardial infarction in man?

Cytokine

Volumn 50, Issue 2, 2010, Pages 158-162

  Weir, Robin A P ^a   Murphy, Charles Aengus ^a   Petrie, Colin J ^a   Martin, Thomas N ^a   Clements, Suzanne ^a   Steedman, Tracey ^a   Wagner, Galen S ^b   McMurray, John J V ^a   Dargie, Henry J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac magnetic resonance; Matrix metalloproteinases; Monoctye chemoattractant protein 1; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; EPLERENONE; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; STROMELYSIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ALDOSTERONE ANTAGONISTS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL INFARCTION; SPIRONOLACTONE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

MURINAE;

EID: 77950847865     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.020     Document Type: Article

References (33)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81(4):1161-1172.
2. Rouleau J.L., de Champlain J., Klein M., Bichet D., Moyé L., Packer M., et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 1993, 22(2):390-398.
3. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35(3):569-582.
4. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987, 76(1):44-51.
5. Doughty R.N., Whalley G.A., Walsh H.A., Gamble G.D., López-Sendón J., Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN echo substudy. Circulation 2004, 109(2):201-206. CAPRICORN Echo Substudy Investigators.
6. Pfeffer M.A., Greaves S.C., Arnold J.M., Glynn R.J., LaMotte F.S., Lee R.T., et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation 1997, 95(12):2643-2651.
7. Senior R., Basu S., Kinsey C., Schaeffer S., Lahiri A. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 1999, 137(4 Pt. 1):646-652.
8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342(8875):821-8.
9. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
10. Nelken D.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88(4):1121-1127.
11. Kakio T., Matsumori A., Ono K., Ito H., Matsushima K., Sasayama S. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest 2000, 80(7):1127-1136.
12. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003, 108(17):2134-2140.
13. Dewald O., Zymek P., Winkelmann K., Koerting A., Ren G., Abou-Khamis T., et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005, 96(8):881-889.
14. Yamamoto T., Eckes B., Mauch C., Hartmann K., Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol 2000, 164(12):6174-6179.
15. Weir R.A., Mark P.B., Petrie C.J., Clements S., Steedman T., Ford I., et al. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?. Am Heart J 2009, 157(6):1088-1096.
16. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155(12):5769-5776.
17. Gu L., Tseng S.C., Rollins B.J. Monocyte chemoattractant protein-1. Chem Immunol 1999, 72:7-29.
18. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187(4):601-608.
19. Libby P. Changing concepts of atherogenesis. J Intern Med 2000, 247(3):349-358.
20. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999, 143(1):205-211.
21. Matsumori A., Furukawa Y., Hashimoto T., Yoshida A., Ono K., Shioi T., et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997, 29(1):419-423.
22. Parissis J.T., Adamopoulos S., Venetsanou K.F., Mentzikof D.G., Karas S.M., Kremastinos D.T. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res 2002, 22(2):223-229.
23. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96(1):34-40.
24. Sugano Y., Anzai T., Yoshikawa T., Maekawa Y., Kohno T., Mahara K., et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005, 65(2):446-456.
25. Siwik D.A., Chang D.L., Colucci W.S. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000, 86(12):1259-1265.
26. Gharaee-Kermani M., Denholm E.M., Phan S.H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996, 271(30):17779-17784.
27. Squire I.B., Evans J., Ng L.L., Loftus I.M., Thompson M.M. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 2004, 10(4):328-333.
28. Tziakas D.N., Chalikias G.K., Hatzinikolaou E.I., Stakos D.A., Tentes I.K., Kortsaris A., et al. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction. Am J Cardiol 2005, 96(1):31-34.
29. Matsunaga T., Abe N., Kameda K., Hagii J., Fujita N., Onodera H., et al. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction. Int J Cardiol 2005, 105(2):203-208.
30. Kelly D., Cockerill G., Ng L.L., Thompson M., Khan S., Samani N.J., et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 2007, 28(6):711-718.
31. Wagner D.R., Delagardelle C., Ernens I., Rouy D., Vaillant M., Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006, 12(1):66-72.
32. Kelly D., Khan S., Cockerill G., Ng L.L., Thompson M., Samani N.J., et al. Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 2008, 10(2):133-139.
33. Ikonomidis J.S., Hendrick J.W., Parkhurst A.M., Herron A.R., Escobar P.G., Dowdy K.B., et al. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice. effects of exogenous MMP inhibition. Am J Physiol Heart Circ Physiol 2005, 288(1):H149-H158.